Article

Safilo to acquire Polaroid Eyewear

Safilo Group has signed an agreement with StyleMark for the acquisition of the Polaroid Eyewear business.

Padua, Italy-Safilo Group has signed an agreement with StyleMark for the acquisition of the Polaroid Eyewear business.

Safilo will acquire the Polaroid Eyewear business for a consideration of $87.5 million (U.S.) or a maximum €65 million, as determined based on predetermined currency conversion mechanisms. The completion of the acquisition, which is subject to conditions set forth in the contractual documentation, is expected to occur during the first quarter of 2012. 

According to Safilo, the inclusion of the Polaroid Eyewear business into its portfolio represents an offering in a market segment with a high growth potential, especially in markets outside Europe where Polaroid is currently underrepresented and where the distribution network of Safilo Group will allow a prompt expansion.

“We are extremely happy to announce that a historical yet contemporary brand like Polaroid is becoming part of the new Safilo, bringing along its reputation of leader in the manufacturing of high-quality polarizing lenses and the distribution of world-class polarized sunglasses around the world,” said Roberto Vedovotto, chief executive officer of Safilo Group. “The size of the polarizing eyewear market is rising steadily as more and more consumers realize the benefits and the value of glare-free vision. I am confident that a brand like Polaroid will help us in giving a strong push in the use of such important technology.”

For more articles in this issue of Ophthalmology Times eReport, click here.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
© 2025 MJH Life Sciences

All rights reserved.